New Cervical Cancer Vaccine Results From URMC Researchers’ Work
One of the greatest breakthroughs in cancer prevention has its
origins in research done by three virologists at the University
of Rochester Medical Center. Richard Reichman, M.D., William
Bonnez, M.D., and Robert Rose, Ph.D., discovered a method to
protect against several strains of human papillomavirus (HPV),
including those that cause the most prevalent forms of cervical
cancer. This research led Merck & Co. to develop Gardasil®, the
first pure anti-cancer vaccine, approved by the U.S. Food and
Drug Administration (FDA) in June, 2006. More information about
the New Cervical Cancer Vaccine Optimized Brachytherapy For
Prostate Cancer A software-based device called PIPER (Prostate
Implant Planning Engine for Radiotherapy) was developed and
patented by the University of Rochester Medical Center in 2001.
Bracytherapy involves surgically implanting tiny radioactive
seeds into the prostate to destroy cancer cells. While
physicians have been using comp